Mirae Asset Global Investments
KRYS icon

Mirae Asset Global Investments’s Krystal Biotech KRYS Stock Holding History

Mirae Asset Global Investments’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$490K Sell
1,318
-207
-14% -$61.8K ﹤0.01% 990
2026
Q1 		$394K Buy
1,525
+116
+8% +$30.9K ﹤0.01% 979
2025
Q4 		$347K Buy
1,409
+290
+26% +$61K ﹤0.01% 1061
2025
Q3 		$198K Buy
1,119
+3
+0.3% +$449 ﹤0.01% 1125
2025
Q2 		$153K Buy
1,116
+152
+16% +$22.3K ﹤0.01% 1079
2025
Q1 		$177K Buy
964
+6
+0.6% +$1.01K ﹤0.01% 1064
2024
Q4 		$153K Sell
958
-81
-8% -$14.4K ﹤0.01% 1086
2024
Q3 		$184K Buy
1,039
+186
+22% +$35.9K ﹤0.01% 1095
2024
Q2 		$156K Sell
853
-11,148
-93% -$1.87M ﹤0.01% 1087
2024
Q1 		$1.19M Sell
12,001
-1,483
-11% -$206K ﹤0.01% 1439
2023
Q4 		$1.67M Buy
13,484
+969
+8% +$107K ﹤0.01% 1339
2023
Q3 		$1.45M Buy
12,515
+566
+5% +$69.1K ﹤0.01% 1335
2023
Q2 		$1.4M Sell
11,949
-563
-4% -$57.5K ﹤0.01% 1392
2023
Q1 		$1M Buy
12,512
+2,311
+23% +$182K ﹤0.01% 1546
2022
Q4 		$808K Buy
+10,201
New +$757K ﹤0.01% 1618

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mirae Asset Global Investments's KRYS Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Krystal Biotech (KRYS) stake by 14% in Q2 2026, selling an estimated $61.8K and leaving 1,318 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #990.

Mirae Asset Global Investments first reported a position in KRYS in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.67M in Q4 2023. 207 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Mirae Asset Global Investments held 1,318 shares of Krystal Biotech worth $490K as of Q2 2026.
  • Mirae Asset Global Investments sold 207 Krystal Biotech shares in Q2 2026, an estimated $61.8K.
  • Krystal Biotech made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #990 holding.
  • Mirae Asset Global Investments first reported a position in Krystal Biotech in Q4 2022 and has held it in 15 quarters since.
  • Mirae Asset Global Investments's Krystal Biotech position peaked at $1.67M in Q4 2023.
  • 207 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.